Shortcuts

Stuart M. Essig, PhD

Executive Chair, Integra LifeSciences Holdings Corporation

Independent Director

Age: 63

Director since:
July 2017

Committees:
Finance (Chair)
Governance and Corporate Responsibility

Other current public company director service:

  • Integra LifeSciences Holdings Corporation (since 1997) (Executive Chair since Feb. 2024) (Chair, 2012 - 2024)

Former public company director service:

  • Orthofix Medical Inc. (Jan. 2023 - Jun. 2024)
  • Owens & Minor, Inc. (Oct. 2013 - Aug. 2019)
  • SeaSpine Holdings Corporation (Jun. 2015 - Jan. 2023) (Lead Director, Jul. 2015 - Jan. 2023)
  • St. Jude Medical, Inc. (Mar. 1999 - Jan. 2017)
  • Vital Signs, Inc. (1998 - 2002)
  • Zimmer Biomet Holdings, Inc. (2005 - 2008)

Experience

Integra LifeSciences Holdings Corporation

  • Executive Chair of Board of Directors (since February 2024)
  • Non-Executive Chair of Board of Directors (June 2012 – February 2024)
  • Executive Chair of Board of Directors (January 2012 – June 2012)
  • Member of Board of Directors (since 1997)
  • Chief Executive Officer (1997 – 2012)


Prettybrook Partners LLC

  • Managing Director (since 2012)


Wellington Partners Advisory AG

  • Venture Partner (since 2013)


TowerBrook Capital Partners

  • Senior Advisor (since 2010)


Goldman, Sachs and Co.

  • Managing Director, M&A, specializing in the medical device, pharmaceutical and biotechnology sectors (1987 – 1997)

Qualifications

  • Executive Leadership: Extensive executive management experience and deep strategic expertise in the global healthcare industry gained from over twenty-five years of experience in developing, executing and overseeing the corporate strategy of Integra LifeSciences Holdings Corporation, a manufacturer of medical devices used in neurosurgery and orthopedic surgery, as its Chief Executive Officer for fifteen years, non-executive board chair from 2012 to 2024 and executive chair since 2024, during which time revenues increased over 100-fold.
  • Corporate Strategy: Substantial experience in developing, assessing, executing and overseeing corporate strategy in the global healthcare industry acquired over the course of his career in various roles, including through his tenure as the Chief Executive Officer of Integra LifeSciences and significant outside board service, as well as his investment banking, venture capital and private equity firm experiences.
  • Corporate Finance: Deep knowledge of capital markets, investment banking, and mergers and acquisitions acquired throughout the course of his career in investment banking, during which he specialized in the medical device, pharmaceutical and biotechnology sectors, and applied throughout his career at Integra LifeSciences and his outside board service.
  • Dr. Essig also brings significant corporate governance, innovation and R&D, human capital management, financial acumen, international business, operations and risk oversight skills and experience to the Board. 

Education

  • BA, School of Public and International Affairs at Princeton University
  • MBA, University of Chicago
  • PhD, Financial Economics, University of Chicago